Mutual Recognition Agreements MRA
MRAs remove technical barriers to trade by facilitating the mutual recognition of conformity assessments. This eliminates the need for duplicate testing, facilitates market access and makes trade more efficient.
General Information - International Agreements (Mutual Recognition Agreements - MRA)
The MRA’s objective is to reduce technical barriers to trade and to provide products largely unfettered access to foreign markets.
Mutual recognition with the EEA/EFTA states and Turkey
Switzerland has extended the mutual recognition of conformity assessments beyond the EU, both with the EEA/EFTA states (EFTA Convention, Annex I) and with Turkey (EFTA–Turkey Free Trade Agreement, Annex V).
MRA Switzerland - EU
The Agreement on Mutual Recognition of Conformity Assessments (MRA) concluded between Switzerland and the EU has, since 2002, facilitated trade in numerous industrial products by removing technical barriers to trade.
MRA Switzerland - Canada
The MRA between Switzerland and Canada has been in force since 1 May 1999.
MRA Switzerland - UK
Switzerland has concluded two MRAs with the United Kingdom of Great Britain and Northern Ireland (UK). One based on harmonised legislation and one that takes into account the regulations of the contracting partner.
MRA GMP Switzerland - South Korea
In Switzerland and South Korea, medicines are produced under GMP (PIC/S). These rules ensure quality, control, and patient safety.
MRA GMP Switzerland - USA
Medicine manufacturers in Switzerland and the United States have to comply with the standards of good manufacturing practice (GMP). The GMP rules are agreed at international level (PIC/s).
Contact persons
For further information, please contact the following departments directly. This directory serves as a guide for technical or coordination-related inquiries.